Ann Arbor, MI Clinical Trials Report — May 2026

Ann Arbor, MI, continues to be a vibrant hub for clinical research, with opportunities for patients and healthy volunteers to contribute to medical advancements. As May 2026 unfolds, prospective participants should note that 53 clinical trials are slated to conclude enrollment within the next 90 days, making prompt action essential for those interested.

Among these rapidly closing studies, 9 trials are still actively seeking healthy volunteers, offering a chance to contribute to medical science before their enrollment windows close. For individuals managing specific health conditions, trials focused on various areas are also nearing their deadlines. Conditions with trials closing soon include:

• Breast cancer (2 trials)
• Adenoid cystic carcinoma (1 trial)
• Amputation neuroma (1 trial)
• Advanced solid tumor (1 trial)
• Age-related macular degeneration (1 trial)
• Aggression (1 trial)
• Adolescent (1 trial)
• Amyotrophic lateral sclerosis (1 trial)
• Aortic insufficiency (1 trial)
• Aortic regurgitation (1 trial)

New Research Opportunities in Ann Arbor

This month, Ann Arbor welcomed 9 new clinical trials, a decrease from the 14 trials that launched in April 2026. Despite this dip, the city maintains a robust research landscape with 950 clinical trials currently recruiting across 220 research facilities.

May brings several notable new trials to Ann Arbor, including studies from academic institutions and industry sponsors. These trials offer participants the chance to engage with cutting-edge treatments and diagnostic approaches across a range of health challenges.

• Carelon Research is sponsoring NCT07582861, "Prenatally-initiated Psychological Intervention for Mothers of Infants With Congenital Heart Disease (CHD)." This two-arm, prospective, longitudinal, randomized controlled trial (RCT) aims for 210 participants and will compare usual care to usual care plus a prenatally initiated, virtually administered psychological intervention, called HeartGPS.
• Oregon Health and Science University is leading NCT07594145, "Precision T1D Platform - New Therapies for Cardio-Renal Complications." This Phase 2 study, targeting 57 participants, is part of a joint University of Michigan-Oregon Health & Science University Center of Excellence (CoE) to address cardio-renal complications in Type 1 Diabetes (T1D). The overarching hypothesis is that individuals with T1D have unique endophenotypes determining their progression.

New trials this month are exploring a variety of conditions, including aging, atrial arrhythmia, atrial fibrillation, behavior change, cardio-renal vascular function and failure, clostridioides difficile infection, cognitive ability, congenital diaphragmatic hernia, congenital heart disease (CHD), and HIV pre-exposure prophylaxis. Behavioral trials and "OTHER" trial types each account for 3 new studies, followed by combination product, device, and drug trials with 1 each.

Leading Research Facilities in Ann Arbor

Ann Arbor is home to some of Michigan's leading research institutions, which consistently run a high volume of clinical trials. These facilities are key destinations for individuals seeking to participate in medical research:

• University of Michigan (386 trials)
• University of Michigan Rogel Cancer Center (76 trials)
• Trinity Health Saint Joseph Mercy Hospital Ann Arbor (69 trials)
• University of Michigan Comprehensive Cancer Center (34 trials)
• C S Mott Children's Hospital (32 trials)
• Research Site (26 trials)
• University of Michigan Health System (23 trials)
• University of Michigan Hospital (21 trials)
• VA Ann Arbor Healthcare System, Ann Arbor, MI (19 trials)
• C.S. Mott Children's Hospital (16 trials)

The University of Michigan and its affiliated centers, such as the Rogel Cancer Center and C.S. Mott Children's Hospital, dominate the research landscape in Ann Arbor, offering a broad spectrum of studies across numerous medical specialties.

Opportunities for Healthy Volunteers and Diverse Participants

For individuals without a specific medical condition, there are significant opportunities to contribute to research. Of the 9 new trials launched this month, 3 are actively seeking healthy volunteers. Across Ann Arbor, a total of 86 clinical trials are currently recruiting healthy participants, providing numerous avenues for those interested in supporting medical research.

Participation in clinical trials is open to a diverse range of individuals. Of the new trials launched this month, 7 include older adults, ensuring that senior populations have ample opportunity to contribute to medical science. Additionally, 1 new trial includes children, and 1 is female-only. Academic institutions continue to play a vital role in Ann Arbor's research ecosystem, with the University of Michigan sponsoring 4 of the new studies.

Broadening Your Search: Nearby Options in Michigan

While Ann Arbor offers a substantial array of clinical trial opportunities, individuals may also find options in nearby communities within Michigan. Cities with active trials include:

• Grand Rapids (5 trials)
• Southfield (3 trials)
• Detroit (3 trials)
• Farmington Hills (2 trials)
• Troy (2 trials)
• Warren (1 trial)
• Bloomfield Hills (1 trial)
• Ypsilanti (1 trial)

As we move through May, Ann Arbor's dedicated research community will continue to drive medical innovation, offering diverse opportunities for individuals to contribute to the future of healthcare.